This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santin, A. D.
Right arrow Articles by Cannon, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santin, A. D.
Right arrow Articles by Cannon, M. J.

 Previous Article  |  Next Article 

Journal of Virology, May 2000, p. 4729-4737, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes

Alessandro D. Santin,1,2,* Paul L. Hermonat,1 Antonella Ravaggi,1,2 Stefania Bellone,1,2 Sergio Pecorelli,2 Juan J. Roman,1 Groesbeck P. Parham,1 and Martin J. Cannon3

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology,1 and Department of Microbiology and Immunology,3 University of Arkansas for Medical Sciences, Little Rock, Arkansas, and Division of Gynecologic Oncology, University of Brescia, Brescia, Italy2

Received 28 December 1999/Accepted 23 February 2000

Interleukin-10 (IL-10) is widely known as an immunosuppressive cytokine by virtue of its ability to inhibit macrophage-dependent antigen presentation, T-cell proliferation, and Th1 cytokine secretion. However, several studies have challenged the perception of IL-10 solely as an immunosuppressive cytokine. As part of an investigation on potentiation of the cytotoxic activity of human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes (CTL) for adoptive transfusions to cervical cancer patients, we found that IL-10 in combination with IL-2, unlike several other combinations, including IL-2 with IL-12, gamma interferon (IFN-gamma ), tumor necrosis factor alpha, and transforming growth factor beta , was able to consistently increase cytotoxicity. This augmentation in cytotoxic activity correlated with a significant increase in the cytoplasmic accumulation of perforin as detected by fluorescence-activated cell sorter. Surface expression of both the alpha  and beta  chains of the CD8 heterodimeric coreceptor and CD56 molecules was increased by exposure of CTL to IL-10. More importantly, we found that administration of IL-10 in combination with IL-2 after antigen stimulation consistently increased the intracellular expression of Th1 cytokines (i.e., IFN-gamma and IL-2) compared to results for control CD8+ T cells cultured in IL-2 alone. In kinetic studies, proliferation, intracellular perforin levels, cytotoxic activity, and IFN-gamma expression were consistently elevated in CTL cultures containing IL-10 compared to control cultures, both at early and late time points following stimulation. In contrast, intracellular IL-2 expression was consistently increased only at early time points following stimulation with autologous tumor cells or solid-phase anti-CD3 antibody. Taken together, these data support the use of IL-10 in combination with IL-2 for the in vitro expansion and potentiation of tumor-specific CTL for clinical use in the therapy of cancer.

* Corresponding author. Mailing address: UAMS Medical Center, Division of Gynecologic Oncology, University of Arkansas, 4301 W. Markham, Little Rock, AR 72205-7199. Phone: (501) 686-7162. Fax: (501) 686-8091. E-mail: cannonmartin{at}exchange.uams.edu.

Journal of Virology, May 2000, p. 4729-4737, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Slobedman, B., Barry, P. A., Spencer, J. V., Avdic, S., Abendroth, A. (2009). Virus-Encoded Homologs of Cellular Interleukin-10 and Their Control of Host Immune Function. J. Virol. 83: 9618-9629 [Full Text]  
  • Bellone, S., El-Sahwi, K., Cocco, E., Casagrande, F., Cargnelutti, M., Palmieri, M., Bignotti, E., Romani, C., Silasi, D.-A., Azodi, M., Schwartz, P. E., Rutherford, T. J., Pecorelli, S., Santin, A. D. (2009). Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic Vaccines. J. Virol. 83: 6779-6789 [Abstract] [Full Text]  
  • Zhang, G., Rowe, J., Kusel, M., Bosco, A., McKenna, K., de Klerk, N., Sly, P. D., Holt, P. G. (2009). Interleukin-10/Interleukin-5 Responses at Birth Predict Risk for Respiratory Infections in Children with Atopic Family History. Am. J. Respir. Crit. Care Med. 179: 205-211 [Abstract] [Full Text]  
  • Foulds, K. E., Rotte, M. J., Seder, R. A. (2006). IL-10 Is Required for Optimal CD8 T Cell Memory following Listeria monocytogenes Infection. J. Immunol. 177: 2565-2574 [Abstract] [Full Text]  
  • Mocellin, S., Marincola, F. M., Young, H. A. (2005). Interleukin-10 and the immune response against cancer: a counterpoint. J. Leukoc. Biol. 78: 1043-1051 [Abstract] [Full Text]  
  • Lopez, M. V., Adris, S. K., Bravo, A. I., Chernajovsky, Y., Podhajcer, O. L. (2005). IL-12 and IL-10 Expression Synergize to Induce the Immune-Mediated Eradication of Established Colon and Mammary Tumors and Lung Metastasis. J. Immunol. 175: 5885-5894 [Abstract] [Full Text]  
  • Tacken, P. J., de Vries, I. J. M., Gijzen, K., Joosten, B., Wu, D., Rother, R. P., Faas, S. J., Punt, C. J. A., Torensma, R., Adema, G. J., Figdor, C. G. (2005). Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 106: 1278-1285 [Abstract] [Full Text]  
  • Pauschinger, M., Rutschow, S., Chandrasekharan, K., Westermann, D., Weitz, A., Schwimmbeck, L. P., Zeichhardt, H., Poller, W., Noutsias, M., Li, J., Schultheiss, H.-P., Tschope, C. (2005). Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis Association with reduced myocardial interleukin-1{beta} and MMP-8 expression and a modulated immune response. Eur J Heart Fail 7: 444-452 [Abstract] [Full Text]  
  • Kobayashi, A., Greenblatt, R. M., Anastos, K., Minkoff, H., Massad, L. S., Young, M., Levine, A. M., Darragh, T. M., Weinberg, V., Smith-McCune, K. K. (2004). Functional Attributes of Mucosal Immunity in Cervical Intraepithelial Neoplasia and Effects of HIV Infection. Cancer Res. 64: 6766-6774 [Abstract] [Full Text]  
  • DeVoti, J. A., Steinberg, B. M., Rosenthal, D. W., Hatam, L., Vambutas, A., Abramson, A. L., Shikowitz, M. J., Bonagura, V. R. (2004). Failure of Gamma Interferon but Not Interleukin-10 Expression in Response to Human Papillomavirus Type 11 E6 Protein in Respiratory Papillomatosis. CVI 11: 538-547 [Abstract] [Full Text]  
  • Lu, F., Huang, S., Kasper, L. H. (2003). Interleukin-10 and Pathogenesis of Murine Ocular Toxoplasmosis. Infect. Immun. 71: 7159-7163 [Abstract] [Full Text]  
  • Vigouroux, S., Yvon, E., Wagner, H.-J., Biagi, E., Dotti, G., Sili, U., Lira, C., Rooney, C. M., Brenner, M. K. (2003). Induction of Antigen-Specific Regulatory T Cells following Overexpression of a Notch Ligand by Human B Lymphocytes. J. Virol. 77: 10872-10880 [Abstract] [Full Text]  
  • Strauss, G., Knape, I., Melzner, I., Debatin, K.-M. (2003). Constitutive Caspase Activation and Impaired Death-Inducing Signaling Complex Formation in CD95-Resistant, Long-Term Activated, Antigen-Specific T Cells. J. Immunol. 171: 1172-1182 [Abstract] [Full Text]  
  • Asadullah, K., Sterry, W., Volk, H. D. (2003). Interleukin-10 Therapy--Review of a New Approach. Pharmacol. Rev. 55: 241-269 [Abstract] [Full Text]  
  • Dorsey, R., Kundu, N., Yang, Q., Tannenbaum, C. S., Sun, H., Hamilton, T. A., Fulton, A. M. (2002). Immunotherapy with Interleukin-10 Depends on the CXC Chemokines Inducible Protein-10 and Monokine Induced by IFN-{gamma}. Cancer Res. 62: 2606-2610 [Abstract] [Full Text]  
  • McInnes, I. B., Illei, G. G., Danning, C. L., Yarboro, C. H., Crane, M., Kuroiwa, T., Schlimgen, R., Lee, E., Foster, B., Flemming, D., Prussin, C., Fleisher, T. A., Boumpas, D. T. (2001). IL-10 Improves Skin Disease and Modulates Endothelial Activation and Leukocyte Effector Function in Patients with Psoriatic Arthritis. J. Immunol. 167: 4075-4082 [Abstract] [Full Text]  
  • Deckert, M., Soltek, S., Geginat, G., Lutjen, S., Montesinos-Rongen, M., Hof, H., Schluter, D. (2001). Endogenous Interleukin-10 Is Required for Prevention of a Hyperinflammatory Intracerebral Immune Response in Listeria monocytogenes Meningoencephalitis. Infect. Immun. 69: 4561-4571 [Abstract] [Full Text]  
  • Strestik, B. D., Olbrich, A. R. M., Hasenkrug, K. J., Dittmer, U. (2001). The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukaemia virus). J. Gen. Virol. 82: 1349-1354 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»